| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/23/2002 | CA1341379C Purified antithrombin-iii and methods of producing the same |
| 07/18/2002 | WO2002056027A2 Regulation of neutral development by daedalos |
| 07/18/2002 | WO2002055714A2 Human protease and polynucleotides encoding the same |
| 07/18/2002 | WO2002055712A2 Regulation of human alanine aminotransferase |
| 07/18/2002 | WO2002055710A2 Regulation of human purple acid phosphatase |
| 07/18/2002 | WO2002055706A2 Asip-related proteins |
| 07/18/2002 | WO2002055705A2 Proteins and nucleic acids encoding same |
| 07/18/2002 | WO2002055704A2 Proteins, polynucleotides encoding them and methods of using the same |
| 07/18/2002 | WO2002055702A2 Human proteins, polynucleotides encoding them and methods of using the same |
| 07/18/2002 | WO2002055698A2 Transcriptional mediators of blood vessel development and endothelial differentiation |
| 07/18/2002 | WO2002055697A2 Human rhinovirus assays, and compositions comprising anti-rhinoviral perturbagens |
| 07/18/2002 | WO2002055694A2 Discriminative nucleic acid analysis using clone sequence signatures |
| 07/18/2002 | WO2002055693A2 Method for inhibiting the expression of a target gene |
| 07/18/2002 | WO2002055688A2 Histone deacetylase inhibitors in diagnosis and treatment of thyroid neoplasms |
| 07/18/2002 | WO2002055687A2 Transgenic mice containing target gene disruptions |
| 07/18/2002 | WO2002055682A2 56634, a novel human phosphatidylinositol 4-phosphate 5-kinase family member and uses thereof |
| 07/18/2002 | WO2002055675A1 Ancillary composition for the preparation of committed mature dendritic cells |
| 07/18/2002 | WO2002055671A1 Bacillus subtilis var. chungkookjang producing high molecular weight poly-gamma-glutamic acid |
| 07/18/2002 | WO2002055669A2 Regulation of target protein activity through modified proteins |
| 07/18/2002 | WO2002055659A2 Antisense modulation of integrin beta 4 binding protein expression |
| 07/18/2002 | WO2002055558A2 Novel proteins and nucleic acids encoding same |
| 07/18/2002 | WO2002055557A2 Human proteins and nucleic acids encoding same |
| 07/18/2002 | WO2002055555A2 Antigenic ck-18 compounds for therapy and diagnosis and methods for using same |
| 07/18/2002 | WO2002055554A2 Antimicrobial peptides and derived metapeptides |
| 07/18/2002 | WO2002055553A2 Nucleotide sequences and protein(s) encoded by such nucleotides for modulation of apoptosis |
| 07/18/2002 | WO2002055552A2 Soluble cyclic analogues of beta amyloid peptide |
| 07/18/2002 | WO2002055551A1 A novel polypeptide, a human cd63 antigen 56.87 and the polynucleotide encoding the polypeptide |
| 07/18/2002 | WO2002055547A2 Sfrp and peptide motifs that interact with sfrp and methods of their use |
| 07/18/2002 | WO2002055546A1 Angiotensin converting enzyme inhibitors |
| 07/18/2002 | WO2002055545A1 Antimicrobial pseudopeptides |
| 07/18/2002 | WO2002055544A2 Fibrin binding polypeptides useful inter alia in medical imaging processes |
| 07/18/2002 | WO2002055543A2 Hybrid peptides for treatment of bacteremia and septicemia |
| 07/18/2002 | WO2002055542A2 Hpv-specific peptides, which block the binding of hpv to the host cell |
| 07/18/2002 | WO2002055541A2 Peptides having inhibiting activity on the production of nitric oxide |
| 07/18/2002 | WO2002055540A1 New retinol derivatives, the method of preparations and the uses thereof |
| 07/18/2002 | WO2002055537A1 Extractive purification of lipopeptide antibiotics |
| 07/18/2002 | WO2002055536A2 Regulation of target protein activity through modifier proteins |
| 07/18/2002 | WO2002055535A2 Antisense modulation of cytohesin-1 expression |
| 07/18/2002 | WO2002055533A2 Methods of using imxp-888 and imxp-888 antagonists |
| 07/18/2002 | WO2002055532A2 Variant growth hormone molecules conjugated with macromolecular compounds |
| 07/18/2002 | WO2002055498A1 Pharmaceutically active piperidine derivatives |
| 07/18/2002 | WO2002055485A1 Prodrugs of excitatory amino acids |
| 07/18/2002 | WO2002055152A2 Composition for inducing islet neogenesis, containing gastrin/cck receptor ligands and egf receptor ligands |
| 07/18/2002 | WO2002055138A1 A device and a method for dispensing at least two mutually reactive components |
| 07/18/2002 | WO2002055111A2 Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent |
| 07/18/2002 | WO2002055109A2 Generation and/or reduction of new lung tissue in an affected lung, by modulation of the wnt-pathway |
| 07/18/2002 | WO2002055108A1 Targeted modification of intracellular compounds |
| 07/18/2002 | WO2002055106A2 Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors |
| 07/18/2002 | WO2002055102A1 Compositions for treatment of hemorrhaging with activated factor viia in combination with fibrinogen |
| 07/18/2002 | WO2002055101A2 Storage stable powder compositions of interleukin-4 receptor |
| 07/18/2002 | WO2002055100A2 Method and composition for inhibition of tumor growth and enhancing an immune response |
| 07/18/2002 | WO2002055099A2 Modulation of pericyte proliferation using bpi protein products or bpi inhibitors |
| 07/18/2002 | WO2002055098A2 Latency associated peptide for providing latency to pharmaceutically active proteins |
| 07/18/2002 | WO2002055064A2 Mucopolysaccharidosis therapies |
| 07/18/2002 | WO2002055063A2 Fumaric acid amides |
| 07/18/2002 | WO2002055049A1 Cosmetic and/or pharmaceutical preparations |
| 07/18/2002 | WO2002055048A1 Cosmetic and/or pharmaceutical preparations |
| 07/18/2002 | WO2002055024A2 Therapeutic modulation of the tumor inflammatory response |
| 07/18/2002 | WO2002055022A2 Active metabolite of antifungal compound |
| 07/18/2002 | WO2002055019A2 Methods for ameliorating childhood infections |
| 07/18/2002 | WO2002055018A2 Inhibiting gs-fdh to modulate no bioactivity |
| 07/18/2002 | WO2002055010A2 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration |
| 07/18/2002 | WO2002054940A2 Bone morphogenetic protein-2 in the treatment and diagnosis of cancer |
| 07/18/2002 | WO2002054938A2 Treatment of disease by inducing cell apoptosis |
| 07/18/2002 | WO2002054881A2 The use of food and drink as a delevery system for phytase in humans |
| 07/18/2002 | WO2002054872A1 Liquid antimicrobial compositions |
| 07/18/2002 | WO2002054851A2 Inhibition of pathological angiogenesis in vivo |
| 07/18/2002 | WO2002048349A8 Polypeptide capable of binding to heparin |
| 07/18/2002 | WO2002044382A8 Cytokine-like proteins |
| 07/18/2002 | WO2002044198A3 Haplotypes of the slc1a4 gene |
| 07/18/2002 | WO2002039978A8 Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill, the chronically ill and people with malnutrition |
| 07/18/2002 | WO2002034280A3 Use of vanilloid 4 receptor and antagonists or agonists thereof for treating diseases associated with pain |
| 07/18/2002 | WO2002034205A3 Using heat shock proteins to increase immune response |
| 07/18/2002 | WO2002034202A3 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 07/18/2002 | WO2002031114A3 Gene expression modulated in ileitis |
| 07/18/2002 | WO2002031025A3 Biodegradable poly(beta-amino esters) and uses thereof |
| 07/18/2002 | WO2002030359A3 Methods for enhancing lysing of coagulated blood with apolipoprotein e2 phenotype |
| 07/18/2002 | WO2002029088A3 Highly expressible genes |
| 07/18/2002 | WO2002028418B1 Methods of modulating apoptosis by administration of relaxin agonists or antagonists |
| 07/18/2002 | WO2002028414B1 Compositions and methods for wt1 specific immunotherapy |
| 07/18/2002 | WO2002022776A3 Human coagulation factor vii variants |
| 07/18/2002 | WO2002022159A8 Thionin as an antineoplastic and immunostimulant |
| 07/18/2002 | WO2002020597A3 Human vomeronasal receptor-5 |
| 07/18/2002 | WO2002016549A3 METHODS OF TREATMENT OR PREVENTION OF AUTOIMMUNE DISEASES WITH CpG-CONTAINING POLYNUCLEOTIDE |
| 07/18/2002 | WO2002016431A3 PEPTIDES OF THE α1-ADRENERGIC RECEPTOR AND THEIR USE FOR PSORIASIS |
| 07/18/2002 | WO2002015937A3 Pharmaceutical composition for the systematic administration of pharmacologically active ingredients containing polyol fatty acid esters |
| 07/18/2002 | WO2002013758A3 System for regulating in vivo the expression of a transgene by conditional inhibition |
| 07/18/2002 | WO2002008198A3 Novel imidazolidinones as ns3-serine protease inhibitors of hepatitis c virus |
| 07/18/2002 | WO2002006316A3 Alpha-msh related compounds and methods of use |
| 07/18/2002 | WO2002005827A3 Use of natural products in cancer treatment |
| 07/18/2002 | WO2002004516A3 Use of the heat shock protein gp96 |
| 07/18/2002 | WO2002002633A3 Transporters and ion channels |
| 07/18/2002 | WO2002002556A3 AZA-BRIDGED-BICYCLIC AMINO ACID DERIVATIVES AS α4 INTEGRIN ANTAGONISTS |
| 07/18/2002 | WO2002002143A3 Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents |
| 07/18/2002 | WO2001094391A3 Intracellular signaling proteins |
| 07/18/2002 | WO2001092302A3 Human cyslt2 nucleic acids, polypeptides, and uses thereof |
| 07/18/2002 | WO2001090366A3 Human polynucleotides and polypeptides encoded thereby |
| 07/18/2002 | WO2001090328A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/18/2002 | WO2001090325A3 50365, a hexokinase family member and uses thereof |
| 07/18/2002 | WO2001088137A3 Human myd88 adapter-like protein and functional fragments thereof |